Witkin, Jeffrey M.

A role for AMPA receptors in mood disorders

Alt, A., Nisenbaum, E. S., Bleakman, D., & Witkin, J. M. (2006) · Biochemical Pharmacology

Treatment of Major DepressionNeuroscience and Neuropharmacology Research

Cited by 238

Mood disorders: Regulation by metabotropic glutamate receptors

Pilc, A., Chaki, S., Nowak, G., & Witkin, J. M. (2008) · Biochemical Pharmacology

Treatment of Major DepressionNeuroscience and Neuropharmacology Research

Cited by 163

The Rapidly Acting Antidepressant Ketamine and the mGlu2/3 Receptor Antagonist LY341495 Rapidly Engage Dopaminergic Mood Circuits

Witkin, J. M., Monn, J. A., Schoepp, D. D., Li, X., Overshiner, C., Mitchell, S. N., Carter, G., Johnson, B., Rasmussen, K., & Rorick-Kehn, L. M. (2016) · The Journal of Pharmacology and Experimental Therapeutics

Treatment of Major DepressionNeurotransmitter Receptor Influence on Behavior

Cited by 105

Antidepressant-like effects of an AMPA receptor potentiator under a chronic mild stress paradigm

Farley, S., Apazoglou, K., Witkin, J. M., Giros, B., & Tzavara, E. T. (2010) · The International Journal of Neuropsychopharmacology

Treatment of Major DepressionNeuroscience and Neuropharmacology Research

Cited by 96

Failed trials for central nervous system disorders do not necessarily invalidate preclinical models and drug targets

Bespalov, A., Steckler, T., Altevogt, B., Koustova, E., Skolnick, P., Deaver, D., Millan, M. J., Bastlund, J. F., Doller, D., Witkin, J., et al. (2016) · Nature Reviews Drug Discovery

Animal testing and alternativesComputational Drug Discovery Methods

Cited by 84

A novel, orally bioavailable nociceptin receptor antagonist, LY2940094, reduces ethanol self-administration and ethanol seeking in animal models

Rorick-Kehn, L. M., Ciccocioppo, R., Wong, C. J., Witkin, J. M., Martinez-Grau, M. A., Stopponi, S., Adams, B. L., Katner, J. S., Perry, K. W., Toledo, M. A., et al. (2016) · Alcoholism: Clinical and Experimental Research

Neurotransmitter Receptor Influence on BehaviorNeuropeptides and Animal Physiology

Cited by 61

mGlu2/3 receptor antagonism: A mechanism to induce rapid antidepressant effects without ketamine-associated side-effects

Witkin, J. M. (2020) · Pharmacology Biochemistry and Behavior

Treatment of Major DepressionNeuroscience and Neuropharmacology Research

Cited by 36